A detailed history of Financial Advisory Partners, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Financial Advisory Partners, LLC holds 38,363 shares of MDT stock, worth $3.11 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
38,363
Previous 39,190 2.11%
Holding current value
$3.11 Million
Previous $3.08 Billion 11.97%
% of portfolio
1.15%
Previous 1.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$76.84 - $91.03 $63,546 - $75,281
-827 Reduced 2.11%
38,363 $3.45 Billion
Q2 2024

Jul 22, 2024

SELL
$78.71 - $87.02 $76,112 - $84,148
-967 Reduced 2.41%
39,190 $3.08 Billion
Q1 2024

Apr 17, 2024

SELL
$82.84 - $88.09 $493,809 - $525,104
-5,961 Reduced 12.93%
40,157 $3.5 Billion
Q4 2023

Jan 12, 2024

BUY
$69.43 - $83.43 $569,464 - $684,292
8,202 Added 21.63%
46,118 $3.8 Billion
Q3 2023

Nov 03, 2023

BUY
$78.22 - $90.4 $37,623 - $43,482
481 Added 1.28%
37,916 $2.97 Billion
Q2 2023

Oct 04, 2023

BUY
$79.47 - $91.38 $161,403 - $185,592
2,031 Added 5.74%
37,435 $3.3 Billion
Q1 2023

Oct 04, 2023

SELL
$76.72 - $87.58 $5,830 - $6,656
-76 Reduced 0.21%
35,404 $2.85 Billion
Q4 2022

Oct 04, 2023

SELL
$76.18 - $87.74 $25,520 - $29,392
-335 Reduced 0.94%
35,480 $2.76 Billion
Q3 2022

Oct 04, 2023

BUY
$80.75 - $95.31 $44,008 - $51,943
545 Added 1.55%
35,815 $2.89 Billion
Q2 2022

Oct 04, 2023

BUY
$87.4 - $113.09 $217,888 - $281,933
2,493 Added 7.61%
35,270 $3.17 Billion
Q1 2022

Oct 04, 2023

BUY
$100.58 - $112.38 $167,566 - $187,225
1,666 Added 5.36%
32,777 $3.64 Billion
Q4 2021

Oct 04, 2023

BUY
$99.53 - $127.75 $3.1 Million - $3.97 Million
31,111 New
31,111 $3.22 Billion

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Financial Advisory Partners, LLC Portfolio

Follow Financial Advisory Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Partners, LLC with notifications on news.